Status:
UNKNOWN
Biological Collection of Kidney Cells
Lead Sponsor:
University Hospital, Angers
Collaborating Sponsors:
Université de Nantes
Hungarian Academy of Sciences
Conditions:
Pseudoxanthoma Elasticum
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our objective is to obtain human induced pluripotent stem cells from urine samples of PXE patients for further proteomic and metabolomic studies and treatment screening.
Detailed Description
Pseudoxanthoma elasticum (PXE) is a genetic multysystem disorder with cutaneous, ophtalmological and cardiovascular involvement. PXE is associated with mutations of ABCC6 gene coding for the membrane...
Eligibility Criteria
Inclusion
- Patient with PXE diagnosed on clinical and histological criteria, according to current guidelines
- Patient aged over 18
- Patient informed, having understood the purpose and means of the study and signed the consent of participation
- Patient affiliated to the French social welfare system
Exclusion
- Pregnant or nursing PXE woman
- Patient under guardianship, deprived of liberty by court or administrative decision, hospitalized without consent or admitted to a health or social institution for purposes other than research
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03364504
Start Date
January 1 2018
End Date
December 1 2018
Last Update
December 6 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.